Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout

Objective To examine factors influencing the kinetics of monosodium urate (MSU) crystal dissolution measured with dual-energy computed tomography (DECT) during follow-up of patients with gout.Methods Patients with a diagnosis of gout with baseline knees and feet DECT scans exhibiting MSU crystal vol...

Full description

Saved in:
Bibliographic Details
Main Authors: Tristan Pascart, Victor Laurent, Charlotte Jauffret, Aurore Pacaud, Vincent Ducoulombier, Julie Legrand, Stéphane Verdun, Laurène Norberciak, Jean-François Budzik
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/4/e003725.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206510432550912
author Tristan Pascart
Victor Laurent
Charlotte Jauffret
Aurore Pacaud
Vincent Ducoulombier
Julie Legrand
Stéphane Verdun
Laurène Norberciak
Jean-François Budzik
author_facet Tristan Pascart
Victor Laurent
Charlotte Jauffret
Aurore Pacaud
Vincent Ducoulombier
Julie Legrand
Stéphane Verdun
Laurène Norberciak
Jean-François Budzik
author_sort Tristan Pascart
collection DOAJ
description Objective To examine factors influencing the kinetics of monosodium urate (MSU) crystal dissolution measured with dual-energy computed tomography (DECT) during follow-up of patients with gout.Methods Patients with a diagnosis of gout with baseline knees and feet DECT scans exhibiting MSU crystal volumes ≥0.1 cm3 and at least one follow-up DECT were included. Spearman’s correlation coefficient was used to search for association between change from baseline MSU crystal volume at 6, 12, 18 and 24 months and serum urate (SU) level. Associations between percentage change from the baseline volume of MSU crystal deposits and explanatory variables were assessed using linear mixed models.Results Sixty-two patients (age 67.3±12.8 years; 53 (85%) males) cumulating 104 follow-up DECT scans were included. Overall, SU target levels (<6.0 and <5.0 mg/dL) were achieved by 48 (77%) and 36 (58%) patients, respectively. There was a good correlation (r=0.66; p<0.0001) observed between SU level and percentage change in MSU crystal volume. The median decrease from baseline MSU crystal volume was greater in patients reaching the <5.0 mg/dL SU target than in those reaching ≥5.0 SU <6.0 mg/dL: −85% (95% CI: −94% to −72%) versus −40% (−57% to −22%; p<0.05) at 12 months. In multivariable analysis, time (in days) with a multilevel coefficient of −0.06 (95% CI: −0.08 to −0.03, p<0.001), hypertension (coefficient: 41.87, 95% CI: 16.38 to 67.18, p<0.01) and SU level <5.0 mg/dL (coefficient: −39.46, 95% CI: −70.93 to −8.34, p=0.02) were the only variables significantly associated with MSU crystal volume change.Conclusion In patients with DECT-measured MSU crystal deposition, reaching the <5.0 mg/dL SU target provides more extensive and rapid crystal dissolution than reaching the <6.0 mg/dL SU target.
format Article
id doaj-art-be76e2a820a648f3a94d4fbb478c1753
institution Kabale University
issn 2056-5933
language English
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-be76e2a820a648f3a94d4fbb478c17532025-02-07T08:50:14ZengBMJ Publishing GroupRMD Open2056-59332023-11-019410.1136/rmdopen-2023-003725Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with goutTristan Pascart0Victor Laurent1Charlotte Jauffret2Aurore Pacaud3Vincent Ducoulombier4Julie Legrand5Stéphane Verdun6Laurène Norberciak7Jean-François Budzik8Department of Rheumatology, Lille Catholic University, Saint-Philibert Hospital, Lomme, FranceDepartment of Rheumatology, Université Catholique de Lille, Lille, FranceRheumatology Department, Lille Catholic University, Saint Philibert Hospital, EA 7446 - ETHICS, Lille, FranceDepartment of Rheumatology, Université Catholique de Lille, Lille, FranceDepartment of Rheumatology, Université Catholique de Lille, Lille, FranceSaint-Philibert Hospital, Lille, FranceResearch Department, Université Catholique de Lille, Lille, FranceSaint-Philibert Hospital, Lille, FranceSaint-Philibert Hospital, Lille, FranceObjective To examine factors influencing the kinetics of monosodium urate (MSU) crystal dissolution measured with dual-energy computed tomography (DECT) during follow-up of patients with gout.Methods Patients with a diagnosis of gout with baseline knees and feet DECT scans exhibiting MSU crystal volumes ≥0.1 cm3 and at least one follow-up DECT were included. Spearman’s correlation coefficient was used to search for association between change from baseline MSU crystal volume at 6, 12, 18 and 24 months and serum urate (SU) level. Associations between percentage change from the baseline volume of MSU crystal deposits and explanatory variables were assessed using linear mixed models.Results Sixty-two patients (age 67.3±12.8 years; 53 (85%) males) cumulating 104 follow-up DECT scans were included. Overall, SU target levels (<6.0 and <5.0 mg/dL) were achieved by 48 (77%) and 36 (58%) patients, respectively. There was a good correlation (r=0.66; p<0.0001) observed between SU level and percentage change in MSU crystal volume. The median decrease from baseline MSU crystal volume was greater in patients reaching the <5.0 mg/dL SU target than in those reaching ≥5.0 SU <6.0 mg/dL: −85% (95% CI: −94% to −72%) versus −40% (−57% to −22%; p<0.05) at 12 months. In multivariable analysis, time (in days) with a multilevel coefficient of −0.06 (95% CI: −0.08 to −0.03, p<0.001), hypertension (coefficient: 41.87, 95% CI: 16.38 to 67.18, p<0.01) and SU level <5.0 mg/dL (coefficient: −39.46, 95% CI: −70.93 to −8.34, p=0.02) were the only variables significantly associated with MSU crystal volume change.Conclusion In patients with DECT-measured MSU crystal deposition, reaching the <5.0 mg/dL SU target provides more extensive and rapid crystal dissolution than reaching the <6.0 mg/dL SU target.https://rmdopen.bmj.com/content/9/4/e003725.full
spellingShingle Tristan Pascart
Victor Laurent
Charlotte Jauffret
Aurore Pacaud
Vincent Ducoulombier
Julie Legrand
Stéphane Verdun
Laurène Norberciak
Jean-François Budzik
Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
RMD Open
title Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
title_full Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
title_fullStr Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
title_full_unstemmed Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
title_short Factors influencing the kinetics of MSU crystal depletion measured with dual-energy CT in patients with gout
title_sort factors influencing the kinetics of msu crystal depletion measured with dual energy ct in patients with gout
url https://rmdopen.bmj.com/content/9/4/e003725.full
work_keys_str_mv AT tristanpascart factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT victorlaurent factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT charlottejauffret factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT aurorepacaud factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT vincentducoulombier factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT julielegrand factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT stephaneverdun factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT laurenenorberciak factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout
AT jeanfrancoisbudzik factorsinfluencingthekineticsofmsucrystaldepletionmeasuredwithdualenergyctinpatientswithgout